Benchmarking a luciferase complementation assay for detecting protein complexes
about
Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assemblyEVER2 protein binds TRADD to promote TNF-α-induced apoptosisLuciferase fragment complementation imaging in preclinical cancer studiesPooled-matrix protein interaction screens using Barcode Fusion GeneticsA versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real timeVirus-host interactomics: new insights and opportunities for antiviral drug discoveryWidespread macromolecular interaction perturbations in human genetic disordersStructure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.Interplay of PKA and Rac: fine-tuning of Rac localization and signaling.Recruitment of RED-SMU1 complex by Influenza A Virus RNA polymerase to control Viral mRNA splicingSplit luciferase complementation assay to detect regulated protein-protein interactions in rice protoplasts in a large-scale format.HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replicationLarge scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for e2 molecular functions.Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damageA comparative approach to characterize the landscape of host-pathogen protein-protein interactions.Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemiaTOX4 and NOVA1 proteins are partners of the LEDGF PWWP domain and affect HIV-1 replicationLoss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.CCHCR1 interacts specifically with the E2 protein of human papillomavirus type 16 on a surface overlapping BRD4 binding.RIG-I self-oligomerization is either dispensable or very transient for signal transduction.AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral AttenuationAmyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other.Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.Modulation of Re-initiation of Measles Virus Transcription at Intergenic Regions by PXD to NTAIL Binding Strength.Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase.Activation of different split functionalities on re-association of RNA-DNA hybridsPathogen receptor discovery with a microfluidic human membrane protein arrayExploration of binary virus-host interactions using an infectious protein complementation assayInfluenza A Virus Polymerase Recruits the RNA Helicase DDX19 to Promote the Nuclear Export of Viral mRNAs.Hepatitis C Virus Proteins Interact with the Endosomal Sorting Complex Required for Transport (ESCRT) Machinery via Ubiquitination To Facilitate Viral Envelopment.Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalities.Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A.Microfluidic large scale integration of viral-host interaction analysis.Complex Regulation Pattern of IRF3 Activation Revealed by a Novel Dimerization Reporter System.Interaction between ORF24 and ORF34 in the Kaposi's Sarcoma-Associated Herpesvirus Late Gene Transcription Factor Complex Is Essential for Viral Late Gene Expression.Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.Proteome-Scale Human Interactomics.Functional variomics and network perturbation: connecting genotype to phenotype in cancer.
P2860
Q24297412-2C28284A-0822-487A-BB2F-C5A3ED3D4D93Q24318990-B70D4DFC-9B59-418D-8C1A-1EF7ECCC6933Q26851635-0FEE73C6-0154-4CFB-B21B-E4247D6280CEQ28114947-C991EA9D-92C0-4693-A110-6084A23343F0Q28253043-48322D67-F821-4892-82E3-CC4E47392929Q28652236-B9C2FAE8-7890-474E-864A-91B1BFB9295EQ28771729-03449DB8-05EB-45B8-A891-10710255A5FDQ30277715-A04104E8-F9C2-4C05-B243-059D70997948Q33573230-AA450ED1-BA2D-441F-97DE-216CA4A9E7F4Q33748942-DDBE5200-97C6-4124-9B6B-487A529177C4Q33830382-A7CCFB47-BBF3-4499-9ABC-AD6D9CA352B2Q34303782-F42DB273-9975-4A31-8094-1656EF077EE7Q34325506-6D5392D7-3CEC-470C-9F93-C122121F7D04Q34342840-DA0A7F86-E232-4255-87DB-D13302FBC394Q34871356-B18CA930-70F6-47CE-BC0F-0D9980DFD409Q35002007-F66BF98D-8C6B-4668-A8C7-237C399A1102Q35060475-BAD285D7-3F79-4304-B85F-AF1ABC0EE206Q35107420-029D227F-9163-4572-A255-DD872CFBF8A1Q35130275-8A4E0F42-BBAB-4D05-B684-68218A46BA93Q35279959-0D49DB48-A5EA-4CC6-93F4-B21315C2E9ADQ35641039-B4D1423F-8E20-4600-B9A9-E871F7680DF6Q35760491-05DA6188-71B7-4C38-8D62-51003BEEEF8EQ35883857-6881C9A7-7B4C-4711-A81D-8692386A430CQ35907803-A28B53A4-8607-4523-8EC3-3C0A72AC7123Q35975438-AA983CCB-4925-435D-BBEA-0E83AA38ED2BQ36218409-53CDB08E-178A-4E9C-B132-BFFA68A16714Q36536947-FBDA352C-0202-482A-975D-0896CD669203Q36745494-654E3758-22A8-4B93-90EE-75A10ADD05E0Q36831548-85160BD3-0CC2-45AE-BDA9-6977B680F57EQ37214687-1D8F876E-E9F8-4248-8FE0-4132E7C27C40Q37285978-5361305E-9194-4907-A018-6842AE2A8C7FQ37385740-D21282EC-664C-4370-BC14-3A6351EEE43FQ37574140-E7390A51-A494-49E7-97AC-E2CAC1257E2FQ37643752-AFB2728D-4F83-4865-9DE2-7D9846B46A7EQ38104272-E0467A24-06ED-47B8-B06C-6EB82F910841Q38780664-1D52EFA9-9AAC-4530-B460-10E8842BEBD0Q38827801-2DBD1A6A-1DE8-4B7A-B6D4-17F1045BC703Q38870528-29DC280D-9D51-4853-A8A5-631DA64A09DEQ38913438-E351F0C8-1E20-4470-9178-457824B12859Q39201399-9BBE222B-73EF-49B2-9059-AAC23F6CA967
P2860
Benchmarking a luciferase complementation assay for detecting protein complexes
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Benchmarking a luciferase complementation assay for detecting protein complexes
@ast
Benchmarking a luciferase complementation assay for detecting protein complexes
@en
Benchmarking a luciferase complementation assay for detecting protein complexes
@nl
type
label
Benchmarking a luciferase complementation assay for detecting protein complexes
@ast
Benchmarking a luciferase complementation assay for detecting protein complexes
@en
Benchmarking a luciferase complementation assay for detecting protein complexes
@nl
prefLabel
Benchmarking a luciferase complementation assay for detecting protein complexes
@ast
Benchmarking a luciferase complementation assay for detecting protein complexes
@en
Benchmarking a luciferase complementation assay for detecting protein complexes
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Benchmarking a luciferase complementation assay for detecting protein complexes
@en
P2093
Caroline Rolloy
Françoise Vuillier
Fréderic Tangy
Johann Pellet
Mandy Muller
Michel Favre
Patricia Cassonnet
Thibault Chantier
P2860
P2888
P304
P3181
P356
10.1038/NMETH.1773
P407
P577
2011-11-29T00:00:00Z
P5875
P6179
1018587816